{
    "case_number": "CAC-UDRP-102657",
    "time_of_filling": "2019-09-05 09:58:50",
    "domain_names": [
        "ch-novartis.com"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "BRANDIT GmbH",
    "respondent": [
        "Niklas Fischer"
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nThe Complainant claims that the Complainant is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. The Complainant asserts that the Complainant manufactures drugs such as clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan) and many others, which are sold in about 155 countries and reached nearly 800 million people globally in 2018.",
    "other_legal_proceedings": "There are no other legal proceedings the Panel is aware of which are pending or decided and which relate to the disputed domain name.",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).  ",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).  ",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).  ",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Prof. Dr. Lambert Grosskopf, LL.M.Eur."
    ],
    "date_of_panel_decision": "2020-01-02 00:00:00",
    "informal_english_translation": "The Complainant is the owner of the trademark NOVARTIS as a word in several classes in numerous of countries all over the world including in Switzerland (registration n°1803987, registered on February 15, 1996).\r\n",
    "decision_domains": {
        "CH-NOVARTIS.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}